Protect Pharmaceutical Corporation (PRTT)
OTCMKTS · Delayed Price · Currency is USD
1.030
+0.110 (11.96%)
May 1, 2025, 2:42 PM EDT

Protect Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 2008 - 2012
Period Ending
Jun '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 2008 - 2012
Selling, General & Admin
00.120.040.030.030.02
Upgrade
Operating Expenses
00.120.040.030.030.02
Upgrade
Operating Income
-0-0.12-0.04-0.03-0.03-0.02
Upgrade
Interest Expense
-0.01-0.01----
Upgrade
EBT Excluding Unusual Items
-0.02-0.12-0.04-0.03-0.03-0.02
Upgrade
Other Unusual Items
----0.610.49-
Upgrade
Pretax Income
-0.02-0.12-0.04-0.640.46-0.02
Upgrade
Net Income
-0.02-0.12-0.04-0.640.46-0.02
Upgrade
Net Income to Common
-0.02-0.12-0.04-0.640.46-0.02
Upgrade
Shares Outstanding (Basic)
111000
Upgrade
Shares Outstanding (Diluted)
111000
Upgrade
Shares Change (YoY)
--151.36%718.12%21.25%-
Upgrade
EPS (Basic)
-0.01-0.11-0.04-1.448.48-0.54
Upgrade
EPS (Diluted)
-0.02-0.11-0.04-1.448.48-0.54
Upgrade
EBIT
-0-0.12-0.04-0.03-0.03-0.02
Upgrade
Updated Mar 6, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.